The Use of Hematopoietic Growth Factors to Support Cytotoxic Chemotherapy for Patients with Breast Cancer
- 1 February 1994
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 8 (1) , 233-249
- https://doi.org/10.1016/s0889-8588(18)30198-9
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyEuropean Journal Of Cancer, 1993
- Rapid Delivery of Multiple High-Dose Chemotherapy Courses With Granulocyte Colony-Stimulating Factor and Peripheral Blood-Derived Hematopoietic Progenitor CellsJNCI Journal of the National Cancer Institute, 1992
- Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates.Journal of Clinical Investigation, 1990
- Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.Journal of Clinical Investigation, 1988
- Effect of recombinant and purified human haematopoietic growth factors on in vitro colony formation by enriched populations of human megakaryocyte progenitor cellsBritish Journal of Haematology, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- The Molecular Control of Blood Cell DevelopmentScience, 1987
- Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.The Journal of Experimental Medicine, 1987
- Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSFNature, 1986
- The Granulocyte-Macrophage Colony-Stimulating FactorsScience, 1985